Journal de Mycologie Medicale

Papers
(The H4-Index of Journal de Mycologie Medicale is 16. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-03-01 to 2024-03-01.)
ArticleCitations
Invasive fungal diseases during COVID-19: We should be prepared228
Mucormycosis after Coronavirus disease 2019 infection in a heart transplant recipient – Case report and review of literature77
Thymus vulgaris essential oil and thymol inhibit biofilms and interact synergistically with antifungal drugs against drug resistant strains of Candida albicans and Candida tropicalis74
Mucormycosis treatment: Recommendations, latest advances, and perspectives68
Sporotrichosis caused by Sporothrix brasiliensis in Argentina: Case report, molecular identification and in vitro susceptibility pattern to antifungal drugs51
Treatment and management strategies of onychomycosis45
Antioxidant and antifungal activities of marrubiin, extracts and essential oil from Marrubium vulgare L. against pathogenic dermatophyte strains31
Exploring the molecular mechanism of azole resistance in Aspergillus fumigatus30
Potent in vitro activity of curcumin and quercetin co-encapsulated in nanovesicles without hyaluronan against Aspergillus and Candida isolates29
Critically ill patients with COVID-19 and candidaemia: We must keep this in mind23
First report of COVID-19-associated rhino-orbito-cerebral mucormycosis in pediatric patients with type 1 diabetes mellitus21
Candida albicans interaction with Gram-positive bacteria within interkingdom biofilms19
Fatal aspergillosis complicating severe SARS-CoV-2 infection: A case report19
Terbinafine resistance in dermatophytes: Time to revisit alternate antifungal therapy18
Evolution of fungemia in an Italian region18
Fatal disseminated aspergillosis in an immunocompetent patient with COVID-19 due to Aspergillus ochraceus17
0.023175954818726